PA8454201A1 - Formas de dosificacion de sertralina de liberacion retardada - Google Patents

Formas de dosificacion de sertralina de liberacion retardada

Info

Publication number
PA8454201A1
PA8454201A1 PA19988454201A PA8454201A PA8454201A1 PA 8454201 A1 PA8454201 A1 PA 8454201A1 PA 19988454201 A PA19988454201 A PA 19988454201A PA 8454201 A PA8454201 A PA 8454201A PA 8454201 A1 PA8454201 A1 PA 8454201A1
Authority
PA
Panama
Prior art keywords
dosage forms
delayed
delayed release
release sertraline
position along
Prior art date
Application number
PA19988454201A
Other languages
English (en)
Inventor
William John Curatolo
Hylar Lewis Friedman
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971681&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8454201(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8454201A1 publication Critical patent/PA8454201A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

FORMAS DE DOSIFICACION DE SERTRALINA DE LIBERACION RETARDADA QUE REDUCEN EL TMAX Y REDUCEN LOS EFECTOS SECUNDARIOS. LAS FORMAS ESTAN, POR LO GENERAL, ESPECIALMENTE RETARDADAS POR SER SENSIBLES A SU POSICION A LO LARGO DEL TRACTO GASTROINTESTINAL, O TEMPORALMENTE RETARDADAS POR ESTAR RETARDADAS DURANTE UN PERIODO PREDETERMINADO, INDEPENDIENTE DE SU POSICION A LO LARGO DEL TRACTO GASTROINTESTINAL. SE PRESENTAN ENSAYOS IN VIVO PARA IDENTIFICAR DICHAS FORMAS DE DOSIFICACION.
PA19988454201A 1997-07-01 1998-06-25 Formas de dosificacion de sertralina de liberacion retardada PA8454201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5149997P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
PA8454201A1 true PA8454201A1 (es) 2000-09-29

Family

ID=21971681

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988454201A PA8454201A1 (es) 1997-07-01 1998-06-25 Formas de dosificacion de sertralina de liberacion retardada

Country Status (41)

Country Link
EP (1) EP1007024B1 (es)
JP (1) JP3786715B2 (es)
KR (1) KR100369698B1 (es)
CN (4) CN1475208A (es)
AP (1) AP1199A (es)
AR (1) AR038394A2 (es)
AT (1) ATE245415T1 (es)
AU (1) AU727152B2 (es)
BG (1) BG64742B1 (es)
BR (1) BR9809895A (es)
CA (1) CA2290969C (es)
DE (1) DE69816624T2 (es)
DK (1) DK1007024T3 (es)
DZ (1) DZ2547A1 (es)
EA (1) EA001906B1 (es)
ES (1) ES2202858T3 (es)
GT (1) GT199800091A (es)
HK (1) HK1027982A1 (es)
HN (1) HN1998000099A (es)
HR (1) HRP980376B1 (es)
HU (1) HUP0301787A3 (es)
ID (1) ID23187A (es)
IL (2) IL133081A (es)
IS (1) IS5267A (es)
MA (1) MA24585A1 (es)
NO (1) NO996519L (es)
NZ (1) NZ501249A (es)
OA (1) OA11247A (es)
PA (1) PA8454201A1 (es)
PE (1) PE84399A1 (es)
PL (1) PL337799A1 (es)
PT (1) PT1007024E (es)
SI (1) SI1007024T1 (es)
SK (1) SK173299A3 (es)
TN (1) TNSN98122A1 (es)
TR (1) TR199903295T2 (es)
TW (1) TW575437B (es)
UA (1) UA63953C2 (es)
UY (1) UY25068A1 (es)
WO (1) WO1999001122A1 (es)
ZA (1) ZA985710B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1126826T6 (en) 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
ATE367153T1 (de) * 1999-05-20 2007-08-15 Elan Corp Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
ES2256032T3 (es) 1999-09-03 2006-07-16 Apbi Holdings, Llc Utilizacion de dapoxetina, un inhibidor selectivo de la recaptacion de serotonina, para el tratamiento de una disfuncion sexual.
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
HU230402B1 (hu) * 2000-02-10 2016-04-28 Evonik Röhm Gmbh Bélben oldódó akril bevonó készítmények
CA2420535A1 (en) 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
DK1377276T3 (da) * 2001-04-10 2012-01-02 Sun Pharma Advanced Res Co Ltd Beregning af puls-frigivelsessammensætning
WO2003013480A1 (en) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Improved enteric formulation of fluoxetin
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
EP2586429A1 (en) * 2011-10-26 2013-05-01 Freund Pharmatec Ltd. Multi-unit drug delivery device for pulsatile or sustained release
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法
CN109432038A (zh) * 2018-12-28 2019-03-08 乐普制药科技有限公司 一种含有盐酸舍曲林的肠溶片剂及其制备方法
CN114129540B (zh) * 2021-11-19 2022-07-05 浙江维康药业股份有限公司 一种肝苏胶囊及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0357364B1 (en) * 1988-08-30 1993-07-28 E.I. Du Pont De Nemours And Company A process for flash-spinning dry polymeric plexifilamentary film-fibril strands
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
AU727152B2 (en) 2000-12-07
EA001906B1 (ru) 2001-10-22
JP2000513751A (ja) 2000-10-17
NO996519D0 (no) 1999-12-28
EA199900965A1 (ru) 2000-08-28
NZ501249A (en) 2001-06-29
AP9801278A0 (en) 1998-06-30
HK1027982A1 (en) 2001-02-02
EP1007024A1 (en) 2000-06-14
JP3786715B2 (ja) 2006-06-14
CA2290969A1 (en) 1999-01-14
AR038394A2 (es) 2005-01-12
AU7545198A (en) 1999-01-25
OA11247A (en) 2002-11-19
KR20010013522A (ko) 2001-02-26
KR100369698B1 (ko) 2003-01-30
PE84399A1 (es) 1999-09-11
BR9809895A (pt) 2000-08-01
SK173299A3 (en) 2000-11-07
AP1199A (en) 2003-08-28
ATE245415T1 (de) 2003-08-15
BG103916A (en) 2000-07-31
UY25068A1 (es) 2000-12-29
TW575437B (en) 2004-02-11
IL133081A0 (en) 2001-03-19
HN1998000099A (es) 1998-10-22
NO996519L (no) 2000-02-29
ES2202858T3 (es) 2004-04-01
DE69816624D1 (de) 2003-08-28
CN1151783C (zh) 2004-06-02
TNSN98122A1 (fr) 2005-03-15
CN1494899A (zh) 2004-05-12
DK1007024T3 (da) 2003-11-17
SI1007024T1 (en) 2003-12-31
IS5267A (is) 1999-11-23
MA24585A1 (fr) 1998-12-31
CN1261273A (zh) 2000-07-26
DE69816624T2 (de) 2004-02-19
ID23187A (id) 2000-03-23
IL133081A (en) 2005-09-25
CN1475208A (zh) 2004-02-18
ZA985710B (en) 2000-01-10
TR199903295T2 (xx) 2000-08-21
BG64742B1 (bg) 2006-02-28
WO1999001122A1 (en) 1999-01-14
EP1007024B1 (en) 2003-07-23
HUP0301787A2 (hu) 2003-11-28
DZ2547A1 (fr) 2003-02-08
HRP980376B1 (en) 2002-12-31
GT199800091A (es) 1999-12-21
IL152304A0 (en) 2003-05-29
CA2290969C (en) 2004-02-17
HRP980376A2 (en) 1999-04-30
CN1475209A (zh) 2004-02-18
HUP0301787A3 (en) 2005-04-28
UA63953C2 (uk) 2004-02-16
PT1007024E (pt) 2003-11-28
PL337799A1 (en) 2000-09-11

Similar Documents

Publication Publication Date Title
PA8454201A1 (es) Formas de dosificacion de sertralina de liberacion retardada
IT1276833B1 (it) Coloranti fluorescenti della famiglia della solfo benz e indocianina
ES2172492T1 (es) Dispositivo y procedimiento de aprendizaje del swing de golf.
DE69532660D1 (de) Polarisations-Beleuchtungsvorrichtung und diese verwendender Projektor
ES2052905T3 (es) Sistema de iluminacion decorativa.
ES2071522T3 (es) Dispositivo de sujecion de plastico.
DE69839461D1 (de) Katheter mit Ventileinrichtung
ATE447384T1 (de) Implantierbares band mit einer verbindungsvorrichtung bestehend aus materialien mit unterschiedlichen materialeigenschaften
DK0612234T3 (da) Hygiejnebindssvøb og klæbelapskonstruktion
ES2190110T3 (es) Dispositivo de absorcion y envase intercambiable correspondiente.
KR830006815A (ko) 형광 램프 장치
BR9606486A (pt) Dispositivo salva-vidas com lançador
DE29805883U1 (de) Riemenverbindungsvorrichtung für Schwimmbrillen
DE69017366D1 (de) Endoskop mit austauschbarer Direktsicht-/Seitsichtbeobachtung.
ES2187986T3 (es) Valvula de seguridad.
ECSP982565A (es) Formas de dosificacion de sertralina de liberacion retardada
DE29614078U1 (de) Nasenpflaster mit Werbeaufdruck o.dgl.
ES2136499B1 (es) Corbata.
PE20001167A1 (es) Un dispositivo para el manejo de excrementos con un reborde formado anatomicamente
DK0739201T3 (da) Mikrogranuler af 5-nitro-imidazolderivater
IT238460Y1 (it) Dispositivo avvisatore ed avvistatore luminoso per subacquei.
ES1038260Y (es) Dispositivo de subasta y valoracion para el juego del bridge.
ES1011920Y (es) Dispositivo para el tratamiento de los genitales masculinos.
TR28011A (tr) Aritilmis/saf streptogramin ve hazirlanisi.
DE29605103U1 (de) Not-Kondom-Aufkleber